PapersFlow Research Brief
Esophageal and GI Pathology
Research Guide
What is Esophageal and GI Pathology?
Esophageal and GI pathology encompasses the study of structural and functional disorders affecting the esophagus and gastrointestinal tract, including esophageal perforation, anastomotic leaks, gastroesophageal reflux disease, esophageal cancer, and complications from endoscopic interventions.
This field includes 87,032 published works focused on management techniques such as endoscopic stenting for benign and malignant esophageal diseases, self-expanding metal stents for palliative treatment of gastric outlet obstruction, and endoluminal vacuum therapy for leaks. Key areas cover esophageal atresia, tracheoesophageal fistula, and anastomotic leak management. Preoperative chemoradiotherapy for esophageal or junctional cancer improved survival rates in clinical trials, as shown in van Hagen et al. (2012).
Topic Hierarchy
Research Sub-Topics
Esophageal Perforation Management
Reviews conservative drainage, endoscopic clipping, and surgical repair outcomes stratified by etiology (iatrogenic, Boerhaave) and timing. Studies develop risk scores and comparative effectiveness analyses.
Endoscopic Stenting for Esophageal Leaks
Evaluates fully-covered SEMS migration rates, seal efficacy for anastomotic dehiscences, and removal protocols post-bariatric and oncologic surgery. Meta-analyses compare stenting to other closure techniques.
Endoluminal Vacuum Therapy for GI Leaks
Investigates Endo-SPONGE deployment, closure rates for esophageal and gastric defects, and biofilm management. Multicenter trials assess healing trajectories and predictors of failure.
Self-Expanding Metal Stents for Gastric Outlet Obstruction
Assesses palliation efficacy, stent dysfunction (occlusion, migration), and nutritional outcomes in malignant GOO from pancreatic and gastric cancers. Studies compare enteral stenting to surgical bypass.
Esophageal Atresia and Tracheoesophageal Fistula Repair
Examines primary anastomosis techniques, fistula ligation, and long-term complications like GERD and strictures in neonates. Research evaluates thoracoscopic vs. open approaches and tissue engineering adjuncts.
Why It Matters
Esophageal and GI pathology directly impacts patient outcomes in esophageal cancer treatment, where preoperative chemoradiotherapy followed by surgery increased median overall survival to 49.4 months compared to 24.0 months with surgery alone, according to Shapiro et al. (2015) in the CROSS trial published in The Lancet Oncology. Endoscopic stenting addresses benign and malignant strictures, while self-expanding metal stents provide palliation for gastric outlet obstruction in advanced cases. Management of complications like those from endoscopic biliary sphincterotomy, with rates varying by indication and technique as reported by Freeman et al. (1996) in the New England Journal of Medicine, guides safer procedural practices in surgical and gastroenterological settings. The Montreal consensus definition facilitates standardized GERD diagnosis and management worldwide, per Vakil et al. (2006).
Reading Guide
Where to Start
"Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer" by van Hagen et al. (2012), as it provides a clear clinical trial demonstrating survival improvements from a key intervention, serving as an accessible entry to therapeutic advancements.
Key Papers Explained
"Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer" by van Hagen et al. (2012) established short-term survival benefits, extended by Shapiro et al. (2015) in "Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial," confirming durable outcomes. "Esophageal Cancer" by Enzinger and Mayer (2003) offers epidemiological context, while "The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus" by Vakil et al. (2006) standardizes diagnostics foundational to pathology management. Endoscopic complication papers like Cotton et al. (1991) and Freeman et al. (1996) build procedural safety knowledge.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current work emphasizes evolving techniques in endoscopic stenting, endoluminal vacuum therapy for leaks, and self-expanding metal stents for obstruction palliation, as reflected in the cluster's focus on esophageal perforation and atresia management. No recent preprints or news available, indicating reliance on established trials like CROSS for ongoing refinements.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | A candidate genetic risk factor for vascular disease: a common... | 1995 | Nature Genetics | 5.7K | ✕ |
| 2 | Preoperative Chemoradiotherapy for Esophageal or Junctional Ca... | 2012 | New England Journal of... | 5.3K | ✓ |
| 3 | The Montreal Definition and Classification of Gastroesophageal... | 2006 | The American Journal o... | 3.9K | ✕ |
| 4 | A Quantitative Assessment of Plasma Homocysteine as a Risk Fac... | 1995 | JAMA | 3.6K | ✕ |
| 5 | Plasma Homocysteine as a Risk Factor for Dementia and Alzheime... | 2002 | New England Journal of... | 3.2K | ✓ |
| 6 | Endoscopic sphincterotomy complications and their management: ... | 1991 | Gastrointestinal Endos... | 2.8K | ✕ |
| 7 | Complications of Endoscopic Biliary Sphincterotomy | 1996 | New England Journal of... | 2.5K | ✓ |
| 8 | Esophageal Cancer | 2003 | New England Journal of... | 2.5K | ✕ |
| 9 | Neoadjuvant chemoradiotherapy plus surgery versus surgery alon... | 2015 | The Lancet Oncology | 2.5K | ✕ |
| 10 | MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT | 1977 | Annual Review of Micro... | 2.4K | ✕ |
Frequently Asked Questions
What is the survival benefit of preoperative chemoradiotherapy for esophageal cancer?
Preoperative chemoradiotherapy improved survival among patients with potentially curable esophageal or esophagogastric-junction cancer, with acceptable adverse-event rates, as demonstrated in "Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer" by van Hagen et al. (2012). In the CROSS trial, long-term results showed median overall survival of 49.4 months versus 24.0 months with surgery alone, per Shapiro et al. (2015).
How is gastroesophageal reflux disease defined?
The Montreal Definition classifies gastroesophageal reflux disease based on global evidence consensus, simplifying management and enabling collaborative research across countries, as outlined in "The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus" by Vakil et al. (2006). It accounts for variations in terminology, prevalence, and manifestations.
What are common complications of endoscopic biliary sphincterotomy?
Complications after endoscopic biliary sphincterotomy vary widely based on procedure indication and technique rather than patient age or condition, according to "Complications of Endoscopic Biliary Sphincterotomy" by Freeman et al. (1996). "Endoscopic sphincterotomy complications and their management: an attempt at consensus" by Cotton et al. (1991) provides guidelines for handling these issues.
What is the lifetime risk of esophageal cancer?
Esophageal cancer carries a lifetime risk of 0.8 percent for men and 0.3 percent for women in the United States, increasing with age, with over 50 percent of cases diagnosed at advanced stages, as detailed in "Esophageal Cancer" by Enzinger and Mayer (2003).
What techniques manage esophageal and GI disorders?
Techniques include endoscopic stenting for benign and malignant diseases, self-expanding metal stents for gastric outlet obstruction palliation, and endoluminal vacuum therapy for anastomotic leaks and perforations. These address conditions like esophageal atresia and tracheoesophageal fistula.
Open Research Questions
- ? How can endoscopic techniques be optimized to reduce complication rates in high-risk patients with esophageal perforations or anastomotic leaks?
- ? What long-term outcomes compare endoluminal vacuum therapy to traditional stenting for managing esophageal leaks?
- ? Which patient subgroups derive the greatest survival benefit from neoadjuvant chemoradiotherapy in esophageal or junctional cancers?
- ? How do microbial ecology factors in the gastrointestinal tract influence pathology outcomes in esophageal and gastric diseases?
- ? What refinements in self-expanding metal stents improve patency rates for palliative gastric outlet obstruction?
Recent Trends
The field maintains 87,032 works with a focus on endoscopic stenting, vacuum therapy, and stent palliation for GI obstructions, but growth rate over 5 years is not available.
High-citation papers like van Hagen et al. with 5317 citations and Shapiro et al. (2015) underscore persistent emphasis on neoadjuvant therapy for esophageal cancer.
2012No recent preprints or news in the last 12 months reported.
Research Esophageal and GI Pathology with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Esophageal and GI Pathology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers